ADSM-L

Re: [ADSM-L] Copy Pool Question

2010-07-19 08:03:57
Subject: Re: [ADSM-L] Copy Pool Question
From: Steven Langdale <Steven.Langdale AT CAT DOT COM>
To: ADSM-L AT VM.MARIST DOT EDU
Date: Mon, 19 Jul 2010 13:02:41 +0100
Adrian

Without knowing more about your environment, it's difficult to answer what
is best for you.

Separating the pools by data retention does have it's advantages, one of
which is that reclamation could be more efficient.  However you are going
to end up using more tape media overall.

As for the Disk / tape HBA split, it is recommended that they are.  I've
not personally seen any issues relating to this, but there are people on
here that have if memory serves.

IBM would also recommend this if you called them up.

Steven

Steven Langdale
Global Information Services
EAME Storage Planning and Implementation
Enterprise Architecture - Backup & Recovery Architect









Adrian Compton <acompton AT ASPENPHARMA DOT COM>
Sent by: "ADSM: Dist Stor Manager" <ADSM-L AT VM.MARIST DOT EDU>
19/07/2010 08:56
Please respond to
"ADSM: Dist Stor Manager" <ADSM-L AT VM.MARIST DOT EDU>


To
ADSM-L AT VM.MARIST DOT EDU
cc

Subject
[ADSM-L] Copy Pool Question




Caterpillar: Confidential Green Retain Until: 18/08/2010





Hi All



I have 3 copy pools on my TSM server.

One for normal type retention, one for monthly, and one for yearly.



The though process behind it was that similar type retention data i.e
monthly schedules are moved to monthly copy pools etc.



Am iwrong in doing this.

If I keep them all in one copy poll, is this better, and are there
performance/amount of tapes used issues that I will experience.



I find my offsite's create process are taking forever. I use a TS3310
Tape Library with 6 LTO3 FC drives, on TSm 5.5.4 on AIX 5.3 IBMp570
LPAR.

We have also not split FC tape data and SAN traffic and both are over
the same HBA.



Thanks in advance.



tsm: TSM-PLZ>q stg



Storage         Device          Estimated       Pct       Pct     High
Low     Next Stora-

Pool Name       Class Name       Capacity      Util      Migr      Mig
Mig     ge Pool

                                                                   Pct
Pct

-----------     ----------     ----------     -----     -----     ----
---     -----------

ARCHPOOL        LTO3310DE-        7,089 G       3.0      40.0       90
70

                 VCL

DISKPOOL        DISK              1,501 G      66.1      66.1       98
70     OVERFLOW

DISKPOOL1       DISK              1,500 G      85.2      85.2       98
70     OVERFLOW

INFORMIXMO-     LTO3310DE-       26,084 G       9.7      15.0       90
70

 NTH             VCL

INFORMIXUN-     LTO3310DE-          0.0 M       0.0       0.0       90
70

 LIMITED         VCL

INFORMIXWE-     LTO3310DE-       90,061 G      17.4      24.0       90
70

 EKLY            VCL

INFORMIXYE-     LTO3310DE-        8,192 G       3.1      10.0       90
70

 ARLY            VCL

LEGACY          LTO3310DE-          0.0 M       0.0       0.0       90
70

                 VCL

MONTHPOOL       LTO3310DE-       28,750 G      42.8      56.0       90
70

                 VCL

OFFSITE_33-     LTO3310DE-      308,130 G      17.9

 10              VCL

OFFSITE_MO-     LTO3310DE-       70,410 G      21.1

 NTHLY           VCL

OFFSITE_YE-     LTO3310DE-       81,920 G       0.5

 ARLY            VCL

OVERFLOW        LTO3310DE-       73,675 G      20.2      28.0       90
70

                 VCL

TAPEPOOL        LTO3310DE-      111,220 G      21.7      32.5       90
70

                 VCL

YEARPOOL        LTO3310DE-       16,384 G       0.7       5.0       90
70

                 VCL







Regards



Adrian Compton

Group IT Infrastructure

Pharmacare Limited trading as Aspen Pharmacare

P O Box 4002

Korsten

Port Elizabeth

6014

Switchboard Tel No: +27 (0) 41 407 2111

Tel No: +27 (0) 41 407 2855

Fax: +27 (0) 41 453 7452

Cell: +27 (0) 82 861 7745

No trees were killed in the sending of this message.

However, many electrons were terribly inconvenienced.



Email : acompton AT aspenpharma DOT com   This email is solely for the named
addressee.   Any unauthorised use or interception of this email, or the
review, retransmission, dissemination or other use of, or taking of any
action in reliance upon the contents of this email, by persons or
entities other than the intended recipient, is prohibited. If you are
not the named addressee please notify us immediately by way of a reply
e-mail, and also delete this email and any attached files.

Disclaimer:  You must scan this email and any attached files for viruses
and/or any other defects.  Pharmacare Limited accepts no liability for
any loss, damages or consequence, whether direct, indirect,
consequential or economic, however caused, and whether by negligence or
otherwise, which may result directly or indirectly from this
communication or of any attached files.

<Prev in Thread] Current Thread [Next in Thread>